SCHEMBL7274243

SCHEMBL7274243

CC1SC(=O)NN=C1c1ccc2c(c1)C(=O)C(=O)N2

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 10/20 0.61
PDE3A Q14432 10/20 0.61
PDE4A P27815 7/20 0.61
PDE4B Q07343 7/20 0.61
PDE4C Q08493 7/20 0.61
PDE4D Q08499 7/20 0.61
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
SLC6A11 P48066 1/20 0.45
FBP1 P09467 1/20 0.41
ALDH1A1 P00352 1/20 0.40
TGM2 P21980 5/20 0.40
CES1 P23141 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7267391 0.84 PDE3B (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7268219 0.84 PDE3B (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7273769 0.84 PDE3B (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7273762 0.84 PDE3B (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7266898 0.83 PDE3B (0.55) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7275771 0.83 PDE3B (0.55) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7267048 0.83 PDE3B (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7268184 0.83 PDE3B (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7268181 0.83 PDE3B (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7276133 0.82 PDE3B (0.55) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP claimed
US-5051417-A Indolythiadiazines for treating heart failure LES LABORATOIRES BEECHAM S.A. (FR) 1991-09-24 US disclosed
US-4933336-A Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease LABORATOIRES SOBIO S.A. (FR) 1990-06-12 US disclosed
EP-0351213-A2 2-Indolones substituted in 5 by a cyclic hydrazide radical, their preparation and their use in cardio-active medicaments LES LABORATOIRES BEECHAM S.A. (FR) 1990-01-17 EP disclosed
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP disclosed